• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.60% Nasdaq Down 0.39%

    Acorda Therapeutics, Inc. (ACOR)

    -NasdaqGS
    33.48 Down 2.74(7.56%) Feb 11, 3:59PM EST
    Prev Close:36.22
    Open:35.50
    Bid:29.60 x 100
    Ask:N/A
    1y Target Est:47.67
    Beta:1.57462
    Earnings Date:Apr 28 - May 2 (Est.)
    Day's Range:32.20 - 36.27
    52wk Range:25.50 - 43.63
    Volume:1,101,752
    Avg Vol (3m):635,040
    Market Cap:1.44B
    P/E (ttm):643.85
    EPS (ttm):0.05
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACOR

    Comparison

    Symbol% ChgMkt Cap
    ACORDown 7.56%1.44B
    BIIBDown 2.81%53.60B

    Key Statistics

    Forward P/E (1 yr):35.62
    P/S (ttm):3.24
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :1.04
    Quarterly EPS Est (Mar-16) :0.01
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):1.11

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback